Bernd Schnabl

7PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsMedical biochemistry - lipidsMajor global burdens of diseasePredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 03, 2025
Peroxisome proliferator-activated receptor delta and liver diseases.

Tomoo Yamazaki, Edward E Cable, Bernd Schnabl

|Apr 14, 2023
Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans.

Luca Maccioni, Joyce Kasavuli, Sophie Leclercq

|Feb 22, 2023
IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice.

Noemí Cabré, Phillipp Hartmann, Cristina Llorente

|Jan 27, 2023
Malassezia restricta promotes alcohol-induced liver injury.

Suling Zeng, Phillipp Hartmann, Minji Park

|Jan 11, 2023
Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome.

Cynthia L Hsu, Sonja Lang, Münevver Demir

Pageof 2